For example, in China, the hepatitis B virus surface antigen carrier rate has decreased from 8.75% (1979, before introduction of hepatitis B vaccine) to 7.18% (2006, after introduction of hepatitis B vaccine) [4]. The gene discussed is PPIB; the disease is hepatitis A virus infection.